Based on analyst estimates, the expected revenue for Amgen in Q3 2025 was approximately $9.4 billion and the expected EPS was $5.75. Amgen's reported revenue of $9.557 billion beat expectations by approximately $157 million. The reported EPS of $5.93 also beat expectations by $0.18.
Analysis Details
AI-POWERED INSIGHTSAffected Securities
SourceAMGEN INC
PublishedNovember 4, 2025 at 11:59 PM Historical Context
AI Confidence75% High
ImplicationPotential upside for related securities
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always consult with a qualified financial advisor before making investment decisions.